Ç. Ünal Et Al. , "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group," Oncologist , vol.28, no.10, pp.875-884, 2023
Ünal, Ç. Et Al. 2023. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. Oncologist , vol.28, no.10 , 875-884.
Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... Yalçın, Ş.(2023). Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. Oncologist , vol.28, no.10, 875-884.
Ünal, Çağlar Et Al. "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group," Oncologist , vol.28, no.10, 875-884, 2023
Ünal, Çağlar Et Al. "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group." Oncologist , vol.28, no.10, pp.875-884, 2023
Ünal, Ç. Et Al. (2023) . "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group." Oncologist , vol.28, no.10, pp.875-884.
@article{article, author={Çağlar Ünal Et Al. }, title={Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group}, journal={Oncologist}, year=2023, pages={875-884} }